Related Experiment Video
Updated: Jan 14, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Evidence that testosterone gel does not increase the risk of cardiovascular disease: A Mendelian randomization study
Insights
Testosterone therapy, specifically testosterone gel, was investigated for its link to cardiovascular disease. This Mendelian randomization study found no significant causal relationship, suggesting testosterone treatment does not increase heart disease risk.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Genetics
Background:
- The association between testosterone therapy and cardiovascular disease (CVD) is debated.
- Existing studies show conflicting results, lacking definitive causal evidence.
- Testosterone treatment is prescribed for various conditions, making its safety profile crucial.
Purpose of the Study:
- To investigate the potential causal relationship between testosterone gel use and major cardiovascular diseases.
- To assess risks for stroke, coronary heart disease, hypertension, and cardiomyopathy.
- To employ a robust Mendelian randomization (MR) approach for causal inference.
Main Methods:
- Utilized large-scale Genome-Wide Association Studies (GWAS) data.
- Applied a two-sample Mendelian randomization (MR) analysis.
- Employed inverse variance weighted (IVW) as the primary method, with MR-Egger, weighted median, and weighted mode for sensitivity.
Main Results:
- The primary IVW analysis indicated no significant causal effect of testosterone gel use on overall cardiovascular disease risk.
- Sensitivity analyses, including MR-Egger and weighted median, corroborated the primary findings.
- No significant evidence of horizontal pleiotropy or heterogeneity was detected, supporting result validity.
Conclusions:
- Testosterone gel treatment does not appear to significantly elevate the risk of developing cardiovascular disease.
- Findings contribute to resolving the debate on testosterone therapy safety concerning heart health.
- Further research may explore specific cardiovascular outcomes or patient subgroups.
Background And Objectives:
The potential association between testosterone therapy and cardiovascular disease remains a topic of debate. While some studies suggest a link between testosterone treatment and heart disease, definitive evidence for a causal relationship is lacking. This study aimed to investigate the causal relationship between testosterone gel use and cardiovascular disease, including stroke, coronary heart disease, hypertension, and cardiomyopathy, using a two-sample Mendelian randomization (MR) approach.
Materials And Methods:
This study utilized data from Genome-Wide Association Studies and applied MR analysis to assess causal relationships. The primary method was the inverse variance weighted method, with MR-Egger, weighted median, and weighted mode used as complementary methods. Sensitivity analyses were conducted to evaluate the robustness of the results.
Results:
The inverse variance weighted analysis showed no significant causal link between testosterone gel use and cardiovascular disease risk. Sensitivity analyses revealed no evidence of horizontal pleiotropy or heterogeneity.
Conclusion:
The study findings suggest that testosterone treatment does not significantly increase the risk of developing cardiovascular disease.
Related Concept Videos
Testosterone: Functions and Regulation
Atherosclerosis III: Management
Regression Toward the Mean
What is an Experiment?

